DB
ARA

Dmitry Balyasny’s American Renal Associates Holdings, Inc ARA Stock Holding History

Dmitry Balyasny’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,387
Closed -$195K – 2188
2018
Q2 		$195K Buy
+12,387
New +$195K ﹤0.01% 1651

Other funds holding ARA

CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dmitry Balyasny's ARA Position: Q3 2018 in Review

Dmitry Balyasny sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2018, closing a stake of 12,387 shares — an estimated $195K sold.

Dmitry Balyasny first reported a position in ARA in Q2 2018 and held it in 1 quarter. The position peaked at $195K in Q2 2018. 82 funds tracked by Wall St. Rank hold ARA as of Q3 2018.

  • Dmitry Balyasny reported no remaining American Renal Associates Holdings, Inc position as of Q3 2018 after selling out during the quarter.
  • Dmitry Balyasny sold 12,387 American Renal Associates Holdings, Inc shares in Q3 2018, an estimated $195K.
  • Dmitry Balyasny first reported a position in American Renal Associates Holdings, Inc in Q2 2018 and held it in 1 quarter.
  • Dmitry Balyasny's American Renal Associates Holdings, Inc position peaked at $195K in Q2 2018.
  • 82 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.